Search for: "Director of Patent and Trademark Office" Results 641 - 660 of 2,700
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jun 2021, 10:00 pm
Although the majority held that the unreviewable authority of the APJs violates the Appointments Clause, it nonetheless remedied this violation and preserved the PTAB by giving the US Patent and Trademark Office (USPTO) Director the right to review PTAB decisions. [read post]
22 Jun 2021, 10:00 pm
Although the majority held that the unreviewable authority of the APJs violates the Appointments Clause, it nonetheless remedied this violation and preserved the PTAB by giving the US Patent and Trademark Office (USPTO) Director the right to review PTAB decisions. [read post]
APJs operate within the US Patent and Trademark Office (USPTO), which is a subsection of the Department of Commerce. [read post]
22 Jun 2021, 7:27 am by Anthony B. Cavender
The judges also serve on the Patent Trial and Appeal Board, along with other executives of the Commerce Department’s Patent and Trademark Office. [read post]
21 Jun 2021, 2:47 pm by IPWatchdog
Some were surprised by the conservative Court’s choice to sever the statute and ultimately hand the United States Patent and Trademark Office (USPTO) Director—a political appointee—power to review final decisions, though it was not surprising that they attempted to fashion a solution that would preserve the PTAB and inter partes review (IPR) system. [read post]
21 Jun 2021, 12:07 pm by George Quillin and Jeanne Gills
Patent and Trademark Office must be subject to greater supervision by the agency director in order to comply with the Constitution’s appointments clause. [read post]
21 Jun 2021, 10:52 am by Dennis Crouch
  By design, the US governmental system places presidential political appointees at the top of each executive agency, including the US Patent & Trademark Office so that the US President can then be held directly accountable for the successes and failures. [read post]
7 Jun 2021, 10:00 pm
In response to arguments made by the US government in an appeal pending before the US Supreme Court, members of Congress requested an investigation into the adequacy of due process afforded to Patent Trial and Appeal Board litigants, in particular the amount of supervision and arbitrary control exercised by the director of the US Patent and Trademark Office over PTAB decisionmaking. [read post]
7 Jun 2021, 10:00 pm
In response to arguments made by the US government in an appeal pending before the US Supreme Court, members of Congress requested an investigation into the adequacy of due process afforded to Patent Trial and Appeal Board litigants, in particular the amount of supervision and arbitrary control exercised by the director of the US Patent and Trademark Office over PTAB decisionmaking. [read post]
7 Jun 2021, 10:00 pm
In response to arguments made by the US government in an appeal pending before the US Supreme Court, members of Congress requested an investigation into the adequacy of due process afforded to Patent Trial and Appeal Board litigants, in particular the amount of supervision and arbitrary control exercised by the director of the US Patent and Trademark Office over PTAB decisionmaking. [read post]
7 Jun 2021, 10:00 pm
In response to arguments made by the US government in an appeal pending before the US Supreme Court, members of Congress requested an investigation into the adequacy of due process afforded to Patent Trial and Appeal Board litigants, in particular the amount of supervision and arbitrary control exercised by the director of the US Patent and Trademark Office over PTAB decisionmaking. [read post]
7 Jun 2021, 10:00 pm
In response to arguments made by the US government in an appeal pending before the US Supreme Court, members of Congress requested an investigation into the adequacy of due process afforded to Patent Trial and Appeal Board litigants, in particular the amount of supervision and arbitrary control exercised by the director of the US Patent and Trademark Office over PTAB decisionmaking. [read post]
7 Jun 2021, 10:00 pm
In response to arguments made by the US government in an appeal pending before the US Supreme Court, members of Congress requested an investigation into the adequacy of due process afforded to Patent Trial and Appeal Board litigants, in particular the amount of supervision and arbitrary control exercised by the director of the US Patent and Trademark Office over PTAB decisionmaking. [read post]
5 Jun 2021, 9:36 pm by Patent Docs
Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting, as a virtual meeting, on June 15 and 16, 2021. [read post]
18 May 2021, 7:15 pm by Dennis Crouch
Whether the Federal Circuit err in allowing Intervention by the USPTO Director under, the patent law provision of 35 U.S.C § 143. [read post]
12 May 2021, 1:34 am by Florian Mueller
After Judge Edgar Brinkman's (The Hague) welcome speech, Mary Critharis, the Chief Policy Offier and Director for International Affairs of the United States Patent & Trademark Office originally planned to deliver a keynote address. [read post]
9 May 2021, 9:15 am by Eileen McDermott
Patent and Trademark Office (USPTO) Director Drew Hirshfeld told attendees that patent filings are presently down 3.9% compared to the same time last year; the Office had projected filings would be down 3.7% for the year in the wake of the pandemic, but since filings have been coming in at a greater rate than expected in the last two months, the models now predict an overall 2% decrease for the year... [read post]